121 related articles for article (PubMed ID: 17314326)
1. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
Hocher B; Liefeldt L; Quaschning T; Kalk P; Ziebig R; Godes M; Relle K; Asmus G; Stasch JP
J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
Sahinarslan A; Güz G; Okyay K; Mutluay R; Yalçin R; Bali M; Sindel S; Cengel A
Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
[TBL] [Abstract][Full Text] [Related]
5. Predictive role of BNP and NT-proBNP in hemodialysis patients.
Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C
Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868
[TBL] [Abstract][Full Text] [Related]
6. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
[TBL] [Abstract][Full Text] [Related]
7. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
Deicher R; Ziai F; Bieglmayer C; Schillinger M; Hörl WH
J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
[TBL] [Abstract][Full Text] [Related]
10. Plasma heparin cofactor II activity is an independent predictor of future cardiovascular events in patients after acute myocardial infarction.
Huang SS; Huang PH; Chen YH; Sung SH; Chiang KH; Chen JW; Lin SJ
Coron Artery Dis; 2008 Dec; 19(8):597-602. PubMed ID: 18971786
[TBL] [Abstract][Full Text] [Related]
11. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events.
Vianna AC; Mocelin AJ; Matsuo T; Morais-Filho D; Largura A; Delfino VA; Soares AE; Matni AM
Hemodial Int; 2007 Apr; 11(2):210-6. PubMed ID: 17403173
[TBL] [Abstract][Full Text] [Related]
12. Serum carboxymethyllysine predicts mortality in hemodialysis patients.
Wagner Z; Molnár M; Molnár GA; Tamaskó M; Laczy B; Wagner L; Csiky B; Heidland A; Nagy J; Wittmann I
Am J Kidney Dis; 2006 Feb; 47(2):294-300. PubMed ID: 16431258
[TBL] [Abstract][Full Text] [Related]
13. Circulating E-selectin as a risk marker in patients with end-stage renal disease.
Malatino LS; Stancanelli B; Cataliotti A; Bellanuova I; Fatuzzo P; Rapisarda F; Leonardis D; Tripepi G; Mallamaci F; Zoccali C
J Intern Med; 2007 Oct; 262(4):479-87. PubMed ID: 17875185
[TBL] [Abstract][Full Text] [Related]
14. CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease.
Tanne D; Haim M; Goldbourt U; Boyko V; Reshef T; Adler Y; Benderly M; Mekori YA; Behar S
Int J Cardiol; 2006 Mar; 107(3):322-6. PubMed ID: 16503253
[TBL] [Abstract][Full Text] [Related]
15. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients.
Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J
J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123
[TBL] [Abstract][Full Text] [Related]
16. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study.
Tripepi G; Benedetto FA; Mallamaci F; Tripepi R; Malatino L; Zoccali C
J Am Soc Nephrol; 2007 Apr; 18(4):1316-22. PubMed ID: 17360950
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of heart rate variability in patients with renal failure on hemodialysis.
Oikawa K; Ishihara R; Maeda T; Yamaguchi K; Koike A; Kawaguchi H; Tabata Y; Murotani N; Itoh H
Int J Cardiol; 2009 Jan; 131(3):370-7. PubMed ID: 18199499
[TBL] [Abstract][Full Text] [Related]
18. Predictive significance of blood pressure values for the incidence of cardiovascular events in chronic hemodialysis patients.
Ishimitsu T; Nakano N; Sudo Y; Akashiba A; Takahashi T; Ohta S; Minami J; Matsuoka H
Hypertens Res; 2008 Sep; 31(9):1703-9. PubMed ID: 18971548
[TBL] [Abstract][Full Text] [Related]
19. Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
Kessler M; Zannad F; Lehert P; Grünfeld JP; Thuilliez C; Leizorovicz A; Lechat P;
Nephrol Dial Transplant; 2007 Dec; 22(12):3573-9. PubMed ID: 17611249
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]